ACTG vs MTW

ACTG exhibits severe financial health concerns, evidenced by a Piotroski F-Score of 2/9 (indicating weak fundamentals) and a missing Altman Z-Score, which raises distress risk concerns. Despite a Graham Number of $2.76 suggesting undervaluation, the stock trades at $4.88, implying a premium driven by speculative growth expectations. The company shows erratic earnings performance with massive EPS surprises, including a -2247% miss in 2022 and a 1587% beat in 2021, signaling extreme inconsistency. Profitability remains weak, with negative operating margins (-26.1%) and low ROE (4.31%), while revenue growth is minimal (2.6% YoY). The technical trend is bearish (10/100), and insider activity is neutral, offering no conviction.

MTW presents a stable but fragile financial profile with a Piotroski F-Score of 4/9 and no available Altman Z-Score. While the company is trading at a significant discount to its book value (P/B 0.66) and sales (P/S 0.21), the current price of $13.01 is a premium to both the Graham Number ($9.39) and the growth-based Intrinsic Value ($1.40). A critical disconnect exists between steady revenue growth (13.6%) and a severe collapse in earnings (-88.2%), resulting in an alarmingly thin profit margin of 0.32%. The stock appears to be in a technical downtrend despite a strong 1-year rally, and it currently trades above the analyst target price of $10.50.